Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CDK8 inhibition induces Mediator trapping and impairment of the EWSR1::FLI1 transcriptional program in Ewing sarcoma.

Cancer discovery·2026
Same author

Loss of heterozygosity exposes germline mutations in complex I and drives Warburg metabolism in oncocytic carcinoma of the thyroid.

Science advances·2026
Same author

ScopeViewer: a browser-based solution for visualizing large biological images.

GigaScience·2026
Same author

Modulatory role of fucoidan against monosodium glutamate-induced reproductive and hepatorenal toxicity in adult male rats.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same author

Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-Cell Lymphoma With Distinct Clinicopathologic Features.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

BiGER: Bayesian rank aggregation in genomics with extended ranking schemes.

Nature communications·2026

相关实验视频

Updated: Jun 9, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

利用大型语言模型提取尤文肉瘤的预后病理特征

Jingwei Huang, Ayesha Batool, Zifan Gu

    bioRxiv : the preprint server for biology
    |February 27, 2026
    PubMed
    概括

    大型语言模型 (LLM) 准确地从Ewing瘤病理报告中提取了预后组织学特征. 神经元特异性内酶 (NSE) 表示更高的风险,而S100则表明更好的生存率,特别是在局部疾病中.

    更多相关视频

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
    07:15

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

    Published on: August 16, 2020

    7.6K
    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
    03:14

    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

    Published on: December 6, 2024

    1.3K

    相关实验视频

    Last Updated: Jun 9, 2026

    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.6K
    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
    07:15

    Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

    Published on: August 16, 2020

    7.6K
    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
    03:14

    Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

    Published on: December 6, 2024

    1.3K

    科学领域:

    • 在瘤学瘤学.
    • 医疗信息学 医疗信息学
    • 人工智能在医学中的应用

    背景情况:

    • 目前的尤文肉瘤风险分层主要使用临床因素,如转移状态.
    • 组织学异质性是一种潜在的预后指标,但很难从非结构化的病理学报告中提取出来.
    • 大规模的回顾性分析受到从历史临床试验文件中手动提取数据的劳动密集性限制.

    研究的目的:

    • 验证大型语言模型 (LLM) 的实用性,用于从病理学报告中进行可扩展的数据抽象.
    • 在一个大型的,多机构的尤宁肉瘤患者队列中确定预后组织学特征.
    • 评估人工智能衍生的组织学数据对Ewing肉瘤风险分层的改进影响.

    主要方法:

    • 六个儿童瘤组 (COG) 临床试验中的931名患者的回顾性队列研究.
    • 利用基于LLM的管道从数字化病理报告中提取免疫组织化学 (IHC) 标记物和CD99染色模式.
    • 经过验证的LLM提取精度与人类注释的地面真相和高级专家相对应;使用生存分析评估预后价值.

    主要成果:

    • 该LLM在交叉验证中实现了98.1%的准确性,超过了人类注释者.
    • 神经特异性内酶 (NSE) 的阳性与明显较低的整体存活率 (OS) (HR 2.15) 相关,特别是在非转移性疾病 (HR 5.64) 中.
    • 阳性S100与改善的OS相关 (HR0.58).

    结论:

    • 病理学变量的LLM辅助提取是准确的,可扩展的,并且可以从历史临床试验中解锁有价值的"黑暗数据".
    • NSE和S100被确定为尤宁肉瘤的显著预后生物标志物,特别是在局部疾病中.
    • 人工智能衍生的组织学数据可以完善风险分层,并应考虑未来的潜在临床试验.